IntoCell, Inc. (KOSDAQ:287840)
South Korea
· Delayed Price · Currency is KRW
25,100
+1,200 (5.02%)
At close: Aug 13, 2025, 3:30 PM KST
IntoCell Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Aug '25 Aug 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Debt / Equity Ratio | 2.58 | 1.34 | 0.76 | 0.00 | 0.13 | 0.22 | |
| Asset Turnover | - | 0.12 | 0.06 | - | 0.00 | - | |
| Quick Ratio | 0.80 | 0.99 | 1.59 | 11.80 | 6.40 | 1.28 | |
| Current Ratio | 0.80 | 1.00 | 1.63 | 11.96 | 6.42 | 1.29 | |
| Return on Equity (ROE) | -104.44% | -95.55% | -77.83% | -25.46% | -28.23% | -1307.60% | |
| Return on Assets (ROA) | - | -24.65% | -36.66% | -15.11% | -6.91% | -8.89% | |
| Return on Capital (ROIC) | -29.62% | -29.98% | -40.88% | -16.16% | -10.57% | -76.53% | |
| Buyback Yield / Dilution | -1.47% | -1.07% | 0.00% | -15.73% | -86.09% | -6.35% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.